Services

Five practice areas, each handled end to end.

Our work sits where capital meets commodity flow and clinical infrastructure. Every engagement is taken on a single-mandate basis, led personally by the principals, and carried through to close — or to a candid recommendation that it should not proceed.

Medical technology

From imaging suites to the sterile field.

We supply and facilitate the full spectrum — MRI and CT platforms, robotic and laparoscopic surgical systems, cath-lab and endoscopy suites, and the consumables that keep a hospital running from Monday to Monday.

Laparoscopic surgical instruments on a sterile drape

Two senior advisors in discussion across a boardroom table with Marina Bay in the background

Mergers & Acquisitions

Sell-side and buy-side representation on mid-market cross-border transactions, led directly by the principals from first conversation through to close.

Sell-side and buy-side mandates for privately-held businesses, family-owned groups, and sponsor-backed platforms in the USD 20–250m range.
Deal structuring across Singapore, Mauritius, and holding-company jurisdictions, coordinated with the client's tax and legal counsel.
Counterparty diligence, ultimate-beneficial-ownership checks, and source-of-funds verification carried out before any binding step.
Term-sheet negotiation, definitive-agreement review, and closing coordination — with a single point of accountability throughout.

Commodity Transaction Facilitation

Mandate structuring and documentation for physical commodity trade, with rigorous verification of every counterparty and instrument before either side is asked to commit.

End-to-end mandate structuring for metals, energy, and agricultural commodity flows across the India–Southeast Asia–Africa corridor.
Independent verification of sellers, refineries, tank-farm operators, and end-buyers — including document authentication and prior-performance checks.
Coordination of ICPO, SCO, LOI, and payment-instrument workflows with tier-one banking partners in Singapore, Dubai, and London.
Escrow and inspection arrangements with recognised third parties (SGS, Intertek, Bureau Veritas) where the transaction warrants it.

Modern hospital diagnostic imaging suite with CT scanner

Healthcare Investment Advisory

Capital-raising strategy, governance readiness, and investor positioning for hospital groups, diagnostics chains, and specialty healthcare platforms.

Capital-raising strategy and investor targeting for hospital groups, diagnostics chains, single-specialty platforms, and pharmaceutical operators.
Governance and reporting readiness reviews ahead of institutional or strategic investment.
Positioning advisory and information-memorandum preparation for private-equity, sovereign, and strategic counterparties.
Post-investment governance support during the first two board cycles, where the mandate calls for it.

Robotic surgical system in a modern operating theatre

Medical & Healthcare Product Trading

Sourcing, trading, and cross-border supply of medical technology and healthcare consumables — from advanced surgical platforms and imaging equipment through to disposables and household care lines.

Capital medical equipment: MRI, CT, ultrasound, cath-lab, robotic surgical platforms, and endoscopy systems from tier-one and specialist manufacturers.
Surgical technology: laparoscopic and minimally-invasive instruments, energy devices, orthopaedic implants, and single-use surgical consumables.
General medical consumables: examination and surgical gloves, syringes, IV sets, PPE, wound-care, and diagnostic reagents supplied at institutional scale.
Household and personal care lines under private-label and OEM arrangements, coordinated with vetted manufacturers across India, Malaysia, and Japan.
Manufacturer qualification, CE / FDA / CDSCO documentation review, and coordination of freight, customs, and payment instruments end to end.

Advisory team reviewing corridor strategy in a Singapore boardroom

International Business Development

Market entry, technology collaboration, and partnership facilitation across the India–Singapore–Malaysia–Japan–Africa corridor — with introductions the principals can personally vouch for.

Market-entry strategy, corridor-specific partner mapping, and regulatory-pathway assessment.
Technology-transfer and joint-venture facilitation between manufacturers, licensors, and operating partners.
Warm introductions to distributors, hospital groups, government buyers, and regulatory counsel already known to the firm.
Liaison and monitoring support through first-order fulfilment, first clinical installation, or first commercial milestone.

Have a mandate in mind?

Send a short brief. We reply within two business days.

Start a conversation